BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+30.72%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$3.11B
AUM Growth
+$3.11B
Cap. Flow
-$232M
Cap. Flow %
-7.45%
Top 10 Hldgs %
51.56%
Holding
91
New
16
Increased
7
Reduced
4
Closed
14

Top Buys

1
SPRY icon
ARS Pharmaceuticals
SPRY
$77.6M
2
LABD icon
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$50.5M
3
CYTK icon
Cytokinetics
CYTK
$43.6M
4
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
$42.4M
5
ALGS icon
Aligos Therapeutics
ALGS
$42.2M

Top Sells

1
IMMU
Immunomedics Inc
IMMU
$383M
2
ALLK
Allakos
ALLK
$55M
3
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
$48.8M
4
CGEN icon
Compugen
CGEN
$38.7M
5
QURE icon
uniQure
QURE
$18.6M

Sector Composition

1 Healthcare 96.81%
2 Financials 0.36%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DBVT
51
DBV Technologies
DBVT
$249M
$13M 0.42%
7,534,598
– –
ESPR icon
52
Esperion Therapeutics
ESPR
$490M
$13M 0.42%
500,000
-475,000
-49% -$12.4M
AGEN
53
Agenus
AGEN
$136M
$12.7M 0.41%
4,000,000
– –
SPPI
54
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$11.4M 0.37%
3,333,333
– –
RNAC icon
55
Cartesian Therapeutics
RNAC
$267M
$9.95M 0.32%
3,284,072
– –
NUVB icon
56
Nuvation Bio
NUVB
$1.08B
$9.36M 0.3%
800,000
– –
BLU
57
DELISTED
BELLUS Health Inc.
BLU
$9.1M 0.29%
2,975,000
– –
ASMB icon
58
Assembly Biosciences
ASMB
$183M
$9.08M 0.29%
+1,500,000
New +$9.08M
QURE icon
59
uniQure
QURE
$955M
$9.03M 0.29%
250,000
-515,400
-67% -$18.6M
FSDC
60
DELISTED
FS Development Corp. Class A Common Stock
FSDC
$7.7M 0.25%
700,000
– –
MEIP icon
61
MEI Pharma
MEIP
$149M
$7.69M 0.25%
2,913,091
– –
ORIC icon
62
Oric Pharmaceuticals
ORIC
$1.03B
$6.77M 0.22%
+200,000
New +$6.77M
VINC
63
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$6.27M 0.2%
+300,000
New +$6.27M
BLSA
64
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$6.01M 0.19%
+500,000
New +$6.01M
MIRM icon
65
Mirum Pharmaceuticals
MIRM
$3.75B
$5.54M 0.18%
317,000
– –
JYAC
66
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$5.15M 0.17%
+500,000
New +$5.15M
KNSA icon
67
Kiniksa Pharmaceuticals
KNSA
$2.63B
$5.13M 0.17%
290,577
– –
OBIO icon
68
Orchestra BioMed
OBIO
$147M
$5.12M 0.16%
400,000
– –
TARA icon
69
Protara Therapeutics
TARA
$125M
$5.07M 0.16%
209,227
– –
MLTX icon
70
MoonLake Immunotherapeutics
MLTX
$3.78B
$4.55M 0.15%
+400,000
New +$4.55M
SYRE icon
71
Spyre Therapeutics
SYRE
$1.02B
$4.33M 0.14%
550,000
– –
LJPC
72
DELISTED
La Jolla Pharmaceutical Company
LJPC
$3.46M 0.11%
890,700
– –
GNCA
73
DELISTED
Genocea Biosciences, Inc.
GNCA
$2.75M 0.09%
1,134,453
– –
SNCE
74
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$2.13M 0.07%
+200,000
New +$2.13M
CHFW.U
75
DELISTED
Consonance-HFW Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third
CHFW.U
$2.09M 0.07%
+200,000
New +$2.09M
1 2
3
4